2m 2m 2m 2m 2m 2m 2m
Cytodyn (CYDY)
OTC
$0.20+$0.008 (+3.97%)
Price as of Sep 11, 2026- $273.0MMarket Cap
- -30.89%1-Year Change
- BiotechnologyIndustry
Cytodyn (CYDY)
$0.20+$0.008 (+3.97%)
CYDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.20 | ||
Change | +$0.008 (+3.97%) | ||
Open | $0.19 | ||
High | $0.20 | ||
Low | $0.19 | ||
Previous Close | $0.19 | ||
Volume | 1,600,934 | ||
30-Day Average Volume | 1,563,471 | ||
1-Week Change | -0.88% | ||
1-Month Change | 5.36% | ||
1-Year Change | -30.89% | ||
3-Year Change | -4.19% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.4B | ||
Total Assets | $14.0M | ||
Market Cap | $273.0M | ||
Enterprise Value | $288.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.9M | ||
Free Cash Flow | -$4.9M | ||
EBIT | -$9.9M | ||
EBITDA | -$9.9M | ||
Net Working Capital | -$39.8M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -2 | ||
P/E | -27 | ||
PEG | N/A | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue